Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea flag South Korea · Delayed Price · Currency is KRW
149,600
-2,300 (-1.51%)
At close: Apr 29, 2026

Daewoong Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
195,85624,735121,73942,24024,506
Upgrade
Depreciation & Amortization
51,07248,97843,79739,69540,883
Upgrade
Loss (Gain) From Sale of Assets
-52,328465.97-30,198-246.41,029
Upgrade
Asset Writedown & Restructuring Costs
14,65415,4922,3725,2192,109
Upgrade
Loss (Gain) From Sale of Investments
4,50624,951-130.674,112-8,308
Upgrade
Loss (Gain) on Equity Investments
6,10723,1531,443374.54-257.52
Upgrade
Stock-Based Compensation
475.96545.311,6181,8412,005
Upgrade
Provision & Write-off of Bad Debts
3,0572,1925,8352,2502,125
Upgrade
Other Operating Activities
272.54-6,22610,254-8,8525,813
Upgrade
Change in Accounts Receivable
-8,563-22,597-478.7-23,193-20,692
Upgrade
Change in Accounts Payable
23,294-16,67416,59712,408-8,373
Upgrade
Change in Other Net Operating Assets
-89,199-43,523-36,83842,368-844.34
Upgrade
Operating Cash Flow
149,20551,492136,009118,21539,994
Upgrade
Operating Cash Flow Growth
189.76%-62.14%15.05%195.58%-60.39%
Upgrade
Capital Expenditures
-191,534-155,145-109,338-65,227-29,088
Upgrade
Sale of Property, Plant & Equipment
455.143.051,446483.47257.43
Upgrade
Cash Acquisitions
-2,928--5,807--
Upgrade
Divestitures
--45.59--
Upgrade
Sale (Purchase) of Intangibles
-49,478-73,858-46,289-46,826-45,633
Upgrade
Investment in Securities
-3,928-35,557-8,7916,983-13,220
Upgrade
Other Investing Activities
178.53-636.343,12367.5-
Upgrade
Investing Cash Flow
-247,026-265,451-165,621-106,872-87,683
Upgrade
Short-Term Debt Issued
377,97180,000113,74286,15452,352
Upgrade
Long-Term Debt Issued
310,548325,18765,000149,683108,357
Upgrade
Total Debt Issued
688,519405,187178,742235,837160,709
Upgrade
Short-Term Debt Repaid
-513,468-106,264-87,934-1,212-53,258
Upgrade
Long-Term Debt Repaid
-2,290-92,263-94,201-201,593-91,675
Upgrade
Total Debt Repaid
-515,758-198,527-182,136-202,805-144,933
Upgrade
Net Debt Issued (Repaid)
172,761206,660-3,39433,03215,776
Upgrade
Issuance of Common Stock
--49,890-40,249
Upgrade
Dividends Paid
-8,075-7,741-7,278-8,066-6,458
Upgrade
Other Financing Activities
-334.231,702-0-9,450656.41
Upgrade
Financing Cash Flow
164,352200,62139,21815,51750,224
Upgrade
Foreign Exchange Rate Adjustments
-539.934,782-1,052184.471,073
Upgrade
Miscellaneous Cash Flow Adjustments
-0-0--
Upgrade
Net Cash Flow
65,991-8,5568,55527,0443,608
Upgrade
Free Cash Flow
-42,329-103,65326,67152,98810,906
Upgrade
Free Cash Flow Growth
---49.67%385.84%-85.36%
Upgrade
Free Cash Flow Margin
-2.70%-7.29%1.94%4.14%0.95%
Upgrade
Free Cash Flow Per Share
-3678.75-9008.372334.474786.97991.08
Upgrade
Cash Interest Paid
23,61523,08416,60411,4809,839
Upgrade
Cash Income Tax Paid
14,54838,9018,3919,0505,500
Upgrade
Levered Free Cash Flow
-98,628-174,863-18,388-44,86444,982
Upgrade
Unlevered Free Cash Flow
-90,831-170,496-9,886-39,61051,387
Upgrade
Change in Working Capital
-74,468-82,794-20,72031,583-29,910
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.